ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
RCPI was delisted on the 4th of November, 2015.
36 hedge funds and large institutions have $1.73M invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 29 closing their positions.
91% more call options, than puts
Call options by funds: $193K | Put options by funds: $101K
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
39% less funds holding
Funds holding: 59 → 36 (-23)
51% less capital invested
Capital invested by funds: $3.54M → $1.73M (-$1.81M)
79% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tenor Capital Management
New York
|
+$443K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$293K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$173K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$118K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$89.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
-$1.65M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$80K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$26K |
| 4 |
KCM
Kempner Capital Management
Galveston,
Texas
|
-$24K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$21.4K |
RCPI Hedge Fund Activity: Q2 2015 in Review
36 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q2 2015, worth a combined $1.73M — down 51% from $3.54M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of RCPI and 6 opened new positions — a net loss of 23 holders — while 7 trimmed existing stakes and 11 added.
The largest buyer was Tenor Capital Management, opening a new position worth an estimated $443K. The largest seller was Goldman Capital Management, exiting entirely with an estimated $1.65M sold.
- 36 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q2 2015, down from 59 in Q1 2015.
- Funds reported $1.73M of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q2 2015, down 51% quarter-over-quarter.
- 6 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q2 2015 and 29 closed out, a net change of -23 holders.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2015 was Tenor Capital Management, an estimated $443K added.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) seller in Q2 2015 was Goldman Capital Management, an estimated $1.65M sold.
Based on aggregated 13F filings for Q2 2015.